For Institutional Investors in the US
The Supreme Court’s decision to uphold the legislation may finally bring an end to challenges to the law and further expand health care in the U.S.
A new drug targeting a common mutation found in tumors represents a breakthrough in cancer therapy and a potential new source of growth for biopharma.
Even with an update to its interest rate projections that is perhaps overdue, the Fed can still afford to be patient.
Assessing the recent shift in tone in equity markets and the key themes driving volatility.
Why copper prices have recently been hitting record highs, and implications for investors.
How REITs fared through the pandemic and how they are positioned as economies reopen.
Pondering the question of who is putting money into long-duration bonds at today’s ultra-low rates.
Can surplus cash on corporate balance sheets provide a tailwind for market growth in 2021?
Interpreting the data in China’s latest census, with a focus on pressing economic and societal issues.
Considering the prospects for markets as the global recovery gathers momentum.
How different segments of the tech sector will likely be impacted through each phase of the global economic reopening and recovery.
Clear signs of improvement were seen in global dividend payouts in the first quarter of the year.